Request Deal Involvement

Bain Capital Private Equity to lead a $600m Series B round in Kailera Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ropes & Gray

legal advisors

Ropes & Gray

or

Principals

ROYALTY PHARMA

bidder

ROYALTY PHARMA

KAILERA THERAPEUTICS

target

KAILERA THERAPEUTICS

BAIN CAPITAL PRIVATE EQUITY

bidder

BAIN CAPITAL PRIVATE EQUITY

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

ADAGE CAPITAL MANAGEMENT

bidder

ADAGE CAPITAL MANAGEMENT

CANADA PENSION PLAN INVESTMENT BOARD (CPP INVESTMENTS)

bidder

CANADA PENSION PLAN INVESTMENT BOARD (CPP INVESTMENTS)

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

RTW INVESTMENTS

bidder

RTW INVESTMENTS

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

PERSEVERANCE CAPITAL

bidder

PERSEVERANCE CAPITAL

QATAR INVESTMENT AUTHORITY

bidder

QATAR INVESTMENT AUTHORITY

T ROWE PRICE ASSOCIATES INC

bidder

T ROWE PRICE ASSOCIATES INC

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

SIRONA CAPITAL

bidder

SIRONA CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Bain Capital Private Equity to lead a $600m Series B round in Kailera Therapeutics.